Spirolactam-Based Acetyl-CoA Carboxylase Inhibitors: Toward Improved Metabolic Stability of a Chromanone Lead Structure
- 27 August 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 56 (17), 7110-7119
- https://doi.org/10.1021/jm401033t
Abstract
Acetyl-CoA carboxylase (ACC) catalyzes the rate-determining step in de novo lipogenesis and plays a crucial role in the regulation of fatty acid oxidation. Alterations in lipid metabolism are believed to contribute to insulin resistance; thus inhibition of ACC offers a promising option for intervention in type 2 diabetes mellitus. Herein we disclose a series of ACC inhibitors based on a spirocyclic pyrazololactam core. The lactam series has improved chemical and metabolic stability relative to our previously reported pyrazoloketone series, while retaining potent inhibition of ACC1 and ACC2. Optimization of the pyrazole and amide substituents led to quinoline amide 21, which was advanced to preclinical development.Keywords
This publication has 16 references indexed in Scilit:
- Complementary α-alkylation approaches for a sterically hindered spiro[pyrazolopyranpiperidine]ketoneTetrahedron Letters, 2012
- Soraphen, an inhibitor of the acetyl‐CoA carboxylase system, improves peripheral insulin sensitivity in mice fed a high‐fat dietDiabetes, Obesity and Metabolism, 2009
- Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2Bioorganic & Medicinal Chemistry Letters, 2009
- Novel Indazole Non-Nucleoside Reverse Transcriptase Inhibitors Using Molecular Hybridization Based on Crystallographic OverlaysJournal of Medicinal Chemistry, 2009
- Continuous fat oxidation in acetyl–CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivityProceedings of the National Academy of Sciences, 2007
- Disordered Lipid Metabolism and the Pathogenesis of Insulin ResistancePhysiological Reviews, 2007
- Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2JCI Insight, 2006
- Isozyme-nonselective N-Substituted Bipiperidylcarboxamide Acetyl-CoA Carboxylase Inhibitors Reduce Tissue Malonyl-CoA Concentrations, Inhibit Fatty Acid Synthesis, and Increase Fatty Acid Oxidation in Cultured Cells and in Experimental AnimalsJournal of Biological Chemistry, 2003
- ElogDoct: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral CompoundsJournal of Medicinal Chemistry, 2001
- A new amine catalyzed synthesis of 2-substituted 2,3-dihydro-4H-1,3-benzoxazin-4-onesThe Journal of Organic Chemistry, 1981